XML 40 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Note 1 - Nature of the Business - Schedule of Subsidiaries (Details)
Mar. 31, 2025
Jan. 31, 2025
BeyondSpring Pharmaceuticals Inc. [Member]    
Ownership Percentage in Subsidiaries 100.00%  
BeyondSpring Ltd. [Member]    
Ownership Percentage in Subsidiaries 100.00%  
BeyondSpring HK [Member]    
Ownership Percentage in Subsidiaries 100.00%  
Wanchun Biotechnology Limited [Member]    
Ownership Percentage in Subsidiaries 100.00%  
Wanchun Biotechnology (Dalian) Ltd. [Member]    
Ownership Percentage in Subsidiaries 100.00%  
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member]    
Ownership Percentage in Subsidiaries 57.97%  
Beijing Wanchun Pharmaceutical Technology Ltd. [Member]    
Ownership Percentage in Subsidiaries 57.97%  
SEED Therapeutics Inc. [Member]    
Ownership Percentage in Subsidiaries 37.56% 14.37%
SEED Technology Limited [Member]    
Ownership Percentage in Subsidiaries 57.97%  
SEED Therapeutics US, Inc. [Member]    
Ownership Percentage in Subsidiaries 37.56%  
Wanchun Hongji (Dalian) Pharmaceuticals Ltd. [Member]    
Ownership Percentage in Subsidiaries 37.56%